Cargando…
Cerebral Venous Thrombosis after SARS-CoV-2 Infection and Pfizer-BioNTech Vaccination against COVID-19
In the last 3 years, COVID-19 pandemic has produced great impacts on global population in terms of health and social costs. Pneumonia represents only one of several pathologies associated to COVID-19 disease. Among these, the cerebral venous thrombosis (CVT), constitutes an important cause of stroke...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140082/ https://www.ncbi.nlm.nih.gov/pubmed/35626407 http://dx.doi.org/10.3390/diagnostics12051253 |
_version_ | 1784715011838443520 |
---|---|
author | Nicolardi, Martina Urso, Daniele Luceri, Silvia Logroscino, Giancarlo De Blasi, Roberto |
author_facet | Nicolardi, Martina Urso, Daniele Luceri, Silvia Logroscino, Giancarlo De Blasi, Roberto |
author_sort | Nicolardi, Martina |
collection | PubMed |
description | In the last 3 years, COVID-19 pandemic has produced great impacts on global population in terms of health and social costs. Pneumonia represents only one of several pathologies associated to COVID-19 disease. Among these, the cerebral venous thrombosis (CVT), constitutes an important cause of stroke. Here, we report a case of CVT diagnosed approximately 2 weeks after first dose of Pfizer-BioNTech vaccination, in a patient affected by COVID-19 few months earlier. He presented with headache and severe asthenia. The laboratory tests put in evidence thrombocytopenia and D-dimer elevation. A brain magnetic resonance imaging (MRI) and a computed tomography (CT) demonstrated hemorrhagic and ischemic phenomena on the right ventral thalamic nuclei, left thalamus, hippocampal and parahippocampal regions and the splenium of the corpus callosum. The study revealed a poorly opacified vein of Galeno and straight sinus. Heparin administration improved his clinical status; platelets values also arose over time. |
format | Online Article Text |
id | pubmed-9140082 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91400822022-05-28 Cerebral Venous Thrombosis after SARS-CoV-2 Infection and Pfizer-BioNTech Vaccination against COVID-19 Nicolardi, Martina Urso, Daniele Luceri, Silvia Logroscino, Giancarlo De Blasi, Roberto Diagnostics (Basel) Interesting Images In the last 3 years, COVID-19 pandemic has produced great impacts on global population in terms of health and social costs. Pneumonia represents only one of several pathologies associated to COVID-19 disease. Among these, the cerebral venous thrombosis (CVT), constitutes an important cause of stroke. Here, we report a case of CVT diagnosed approximately 2 weeks after first dose of Pfizer-BioNTech vaccination, in a patient affected by COVID-19 few months earlier. He presented with headache and severe asthenia. The laboratory tests put in evidence thrombocytopenia and D-dimer elevation. A brain magnetic resonance imaging (MRI) and a computed tomography (CT) demonstrated hemorrhagic and ischemic phenomena on the right ventral thalamic nuclei, left thalamus, hippocampal and parahippocampal regions and the splenium of the corpus callosum. The study revealed a poorly opacified vein of Galeno and straight sinus. Heparin administration improved his clinical status; platelets values also arose over time. MDPI 2022-05-18 /pmc/articles/PMC9140082/ /pubmed/35626407 http://dx.doi.org/10.3390/diagnostics12051253 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Interesting Images Nicolardi, Martina Urso, Daniele Luceri, Silvia Logroscino, Giancarlo De Blasi, Roberto Cerebral Venous Thrombosis after SARS-CoV-2 Infection and Pfizer-BioNTech Vaccination against COVID-19 |
title | Cerebral Venous Thrombosis after SARS-CoV-2 Infection and Pfizer-BioNTech Vaccination against COVID-19 |
title_full | Cerebral Venous Thrombosis after SARS-CoV-2 Infection and Pfizer-BioNTech Vaccination against COVID-19 |
title_fullStr | Cerebral Venous Thrombosis after SARS-CoV-2 Infection and Pfizer-BioNTech Vaccination against COVID-19 |
title_full_unstemmed | Cerebral Venous Thrombosis after SARS-CoV-2 Infection and Pfizer-BioNTech Vaccination against COVID-19 |
title_short | Cerebral Venous Thrombosis after SARS-CoV-2 Infection and Pfizer-BioNTech Vaccination against COVID-19 |
title_sort | cerebral venous thrombosis after sars-cov-2 infection and pfizer-biontech vaccination against covid-19 |
topic | Interesting Images |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140082/ https://www.ncbi.nlm.nih.gov/pubmed/35626407 http://dx.doi.org/10.3390/diagnostics12051253 |
work_keys_str_mv | AT nicolardimartina cerebralvenousthrombosisaftersarscov2infectionandpfizerbiontechvaccinationagainstcovid19 AT ursodaniele cerebralvenousthrombosisaftersarscov2infectionandpfizerbiontechvaccinationagainstcovid19 AT lucerisilvia cerebralvenousthrombosisaftersarscov2infectionandpfizerbiontechvaccinationagainstcovid19 AT logroscinogiancarlo cerebralvenousthrombosisaftersarscov2infectionandpfizerbiontechvaccinationagainstcovid19 AT deblasiroberto cerebralvenousthrombosisaftersarscov2infectionandpfizerbiontechvaccinationagainstcovid19 |